That pattern is what researchers reported in the American Journal of Preventive Medicine after the end of pandemic‑era food assistance in parts of the United States. They linked the timing of those rollbacks to a rise in child maltreatment—a finding that lands squarely in the debate over what food security policies do beyond the checkout line.

What changed in the grocery budget—and when

To shore up family budgets early in the pandemic, the U.S. Department of Agriculture authorized Supplemental Nutrition Assistance Program (SNAP) Emergency Allotments starting in early 2020. States began discontinuing those extra allotments on their own timelines between 2021 and 2023.

By the time of the latest reporting, millions of people had lost SNAP assistance over the past year. In practical terms, that meant less cash-equivalent support for food, precisely as prices and rents were still biting in many places.

How the researchers took the measure

The analysis drew on nationwide child welfare data spanning 1,153 U.S. counties between January 2021 and February 2022. Over that window, 10 states ended the expanded SNAP Emergency Allotments, while others did not, creating a natural contrast in timing that could be tracked across counties.

The study period closed in February 2022. That was before a second wave of states ended the emergency allotments between March and August 2022, so any later shifts fall outside the data the researchers examined.

What moved—and what didn’t—in the child welfare numbers

Child maltreatment rates went up in the places where the pandemic‑era extra SNAP benefits ended. The increases showed up in substantiated cases—the ones where investigators concluded maltreatment occurred—rather than in the volume of reports coming in.

Those increases didn’t burst into the statistics all at once. According to lead investigator Liwei Zhang, Ph.D., they appeared gradually over time after the benefits ended, consistent with pressure building as households adjusted to a thinner margin.

The timeline matters beyond the headline

Between March and August 2022, more states rolled back their emergency allotments—but that second wave began after the analytic window closed. The clearest take‑away is therefore anchored to the first phase of rollbacks, not to the nationwide end of emergency allotments that unfolded later.

That boundary matters for interpretation: it pins the finding to a defined period, and it limits what anyone can confidently say about what happened next without fresh data.

What we don’t know yet

The publicly reported results do not quantify by how much substantiated maltreatment rose, nor do they cover outcomes after February 2022. They also don’t specify which types of maltreatment accounted for most of the increase in the summarized findings released so far.

Answering those questions would require updated datasets and disaggregated breakdowns. Until then, the topline remains: substantiated maltreatment rose after the extra SNAP benefits ended, and the number of reports did not significantly increase.

Policy stakes, in plain numbers and dates

SNAP’s emergency boost began in early 2020 and was pulled back on a state‑by‑state schedule from 2021 through 2023. During January 2021 to February 2022—when some states ended the added allotments—child maltreatment rates rose in the counties tracked, with increases building over time and not driven by more reports.

Even without precise effect sizes, that chain of timing and outcome is enough to place child protection squarely in the conversation whenever nutrition assistance is scaled up—or pared back.

A quieter kind of warning

There’s no single alarm bell in these data—no instant spike that settles every argument. Instead, there’s a line that tilts upward as the extra support falls away, across 1,153 counties and a defined slice of time.

It’s an uncomfortable kind of evidence: the absence of a surge in reports, paired with a rise in what investigators confirm. Quiet often, in public health, is the sound a real problem makes.

The post When the extra groceries stopped, another number rose appeared first on Everyman Science.

Over 1,645 Martian days, the rover watched which particles stick, how small they run, and how they differ by surface. The core finding: fine and ultrafine grains—not just the larger, easier‑to‑see stuff—are part of the picture.

Who did this and when we hear more

NASA reports that its Perseverance rover on Mars measured dust on spacesuit material samples carried aboard the vehicle. NASA says the findings will be published Tuesday, Oct. 27. The agency also states these are the first on‑site measurements of fine and ultrafine dust on Mars.

How a rover turned suit swatches into dust monitors

Perseverance carries a small set of five samples of spacesuit material, each a 20‑millimeter (three‑quarters‑inch) square, as part of the calibration target for the SHERLOC instrument. A separate calibration target for the PIXL instrument includes Teflon and basaltic glass. Across 1,645 Martian days, NASA used those surfaces to see what clung and how big it was.

Earlier measurements on Mars could only resolve dust down to about 3 micrometers across. By contrast, NASA reports that PIXL identified two smaller categories: fine particles less than 2.5 micrometers and ultrafine particles around 100 nanometers. For scale, a human hair is about 70 micrometers wide.

What Perseverance actually measured, in numbers

On PIXL’s Teflon target and SHERLOC’s Vectran swatch, particles averaged about 2 micrometers. On PIXL’s basaltic glass and SHERLOC’s Teflon swatch, sizes ranged down to roughly 100 to 300 nanometers. NASA says these results constitute the first on‑site measurement of Martian fine and ultrafine dust. Scott VanBommel, a Perseverance scientist, notes that the existence of ultrafine Mars dust at these sizes had been predicted for a long time; now there are direct measurements to support it.

Beyond size, NASA adds that some materials hold less dust than others—useful information for picking suit fabrics and coatings. Designs such as suitports, which let astronauts enter a suit attached to the outside of a habitat, could reduce how much dust makes it indoors.

Why size matters for astronaut health, in plain terms

NASA states that the health risks of Mars dust depend on how much dust people encounter and for how long. That makes knowing which sizes persist on suit materials important: fine and ultrafine grains are part of what astronauts will bring back to airlocks and living spaces unless designs and procedures prevent it.

The newly resolved sizes are also a reality check for filters, seals, and cleaning tools. Components that work well against micron‑scale grains may need to contend with particles a few hundred nanometers across.

Design implications NASA is already acting on

NASA says it is already working on solutions to extraterrestrial dust hazards. In March 2025, the agency tested an Electrodynamic Dust Shield that used electric fields to clear lunar regolith. The demonstration targeted glass and thermal radiator surfaces on the Moon as a proving ground for future Mars systems.

Procedural defenses matter too. NASA points to options like suitports and dual‑chamber airlocks to keep abrasive or reactive material from entering pressurized spaces. And with Perseverance showing that some materials retain less dust than others, material choice becomes a frontline control.

What we still don’t know from these measurements

The rover data show which particle sizes adhere to specific materials on Perseverance, not how much dust an astronaut would inhale over a shift nor how exposure would accumulate over a mission. NASA underscores that health risks hinge on the quantity of dust and the length of exposure; those two numbers will depend on operations, habitats, and cleaning systems that are not part of these observations.

The measurements come from swatches and calibration targets mounted on a single rover. They don’t, by themselves, map how sizes vary across sites, seasons, or storm conditions. Turning these findings into exposure limits and procedures will take additional measurements and design testing.

The bottom line for Mars missions

NASA reports that Perseverance has now confirmed fine and ultrafine Martian dust on suit‑relevant materials, with sizes averaging around 2 micrometers on some swatches and reaching down to ~100–300 nanometers on others. That’s smaller than earlier Mars measurements could resolve, and it’s a regime engineers and flight surgeons pay attention to when they set requirements.

With some materials holding less dust, and hardware like electrodynamic shields and suitports under development, the path forward is clearer: pick fabrics and coatings with low dust retention, keep dust outside wherever possible, and design systems with nanometer‑scale grains in mind. NASA says more details land Tuesday, Oct. 27.

The post 1,645 Martian days in, Perseverance finds ultrafine Mars dust on suit swatches appeared first on Everyman Science.

In a Nature Physics study, researchers at the RIKEN Center for Emergent Matter Science and collaborators reported that they kept several silicon spin qubits running in parallel while maintaining extremely high accuracy. They worked with an array of five qubits fed by a shared microwave control line and still pushed single‑qubit gate errors down to parts per ten‑thousand—and in one case, parts per hundred‑thousand.

Why this is in the news today

This week’s result lands because parallelism is the roadblock between lab‑scale demonstrations and useful quantum processors. The team reports highly accurate control of several silicon spin qubits operating simultaneously in one chip‑level setup, a capability that underpins any realistic plan to scale silicon devices using shared control hardware.

The intuitive picture, and where it breaks

If you’ve tuned a radio while someone else plays guitar nearby, you know signals can overlap and cause detuning or buzz. It’s tempting to think qubits just “hear” each other’s microwaves the same way. The analogy breaks down because a qubit’s quantum phase—how its wavefunction’s peaks and troughs line up—matters as much as its frequency, and microwave control can shift that phase in subtle, cumulative ways.

The hidden culprit: AC Stark shifts

The team traced a big share of the simultaneous‑operation error to the AC Stark shift: when a microwave drive slightly alters a qubit’s effective energy splitting, its state picks up an unintended phase. In isolation, you calibrate and cancel that. With neighbors driven at the same time, cross‑couplings make those shifts add up unpredictably unless you account for them.

In the study’s five‑qubit array on a shared microwave line, those shifts were the mechanism that quietly degraded accuracy when several qubits were active together. Identifying that specific effect let the researchers target it rather than treating “parallel control” as a vague source of noise.

A scalable fix: pairwise calibration on a shared line

Calibrating every possible multi‑qubit combination would explode in complexity as chips grow. Instead, the researchers implemented a scheme that relies on calibrations performed between pairs of qubits. By measuring and compensating the AC Stark‑induced phase shifts pair by pair, they could predict and correct the composite shifts when larger subsets ran together.

Crucially, the array used a shared microwave control line. That’s a design you can actually lay out across bigger chips, because giving every qubit its own fully independent control hardware doesn’t scale gracefully. The results show that shared control doesn’t have to mean sloppy control—if you calibrate the right thing.

What still fails when you fix the phase

Even after correcting AC Stark shifts, the last sliver of accuracy didn’t vanish. The team linked the remaining loss to drive‑induced decoherence: when you turn up microwave power to steer several qubits at once, you also accelerate processes that sap quantum coherence. That’s not a miscalibrated phase; it’s the quantum state itself losing definition.

Further improvements to device design could mitigate this source of error, according to Leon Camenzind. That points the next round of work toward hardware—materials, layouts, filtering—rather than only smarter pulse shaping.

Why silicon and why shared lines

Silicon spin qubits are built in the same material family as everyday chips, so arrays and control wiring are natural fits for semiconductor processes. That makes the question of wiring density and routability—like whether you can share control lines—more than an academic point; it’s a practical constraint on how many qubits you can fit and actually drive.

By showing highly accurate control with a shared microwave line across five qubits, the study supports architectures that avoid per‑qubit bespoke control. That’s one path toward the stated long‑term goal, from Seigo Tarucha, of building a fault‑tolerant quantum computer based on silicon spin qubits.

What the study doesn’t tell us (yet)

The report gives headline fidelities and identifies AC Stark shifts and drive‑induced decoherence, but it does not specify the detailed hardware geometry or the exact pulse families used to achieve those numbers. It also doesn’t enumerate how the pairwise calibration overhead scales in wall‑clock time on much larger arrays. Those omissions don’t undercut the core result; they just mark where replication studies and engineering follow‑ups will need to fill in specifics.

The road from five to fault‑tolerant

The researchers’ technique shows that accuracy above 99.99% is compatible with running several qubits at once on a shared line, and that even all five together held at about 99.9%. That’s a concrete step toward parallel, scalable control rather than isolated demonstrations.

The team links the residual errors to mechanisms that have engineering handles—calibration for phase shifts, device design for drive‑induced decoherence. As those handles are turned, the long‑term goal, stated by Seigo Tarucha, is a fault‑tolerant quantum computer built from silicon spin qubits.

The post Five silicon qubits share a line—and still hit 99.99% appeared first on Everyman Science.

It’s one of conservation’s most dramatic turnarounds—and one of the most argued‑over. The condor’s path back forced choices about which species to back, what price to pay, and who bears the trade‑offs. Those same choices take center stage this month as governments meet in Yerevan, Armenia, for the U.N. Convention on Biological Diversity.

A recovery told in two numbers: 1987 and 300‑plus

The recovery’s bookends are stark. In 1987, the free‑flying population hit zero when the final wild bird was captured for a last‑chance breeding program. Today, coordinated releases have put more than 300 condors back into wild skies. Those figures don’t explain the breeding protocols or the politics—but they fix the scale of what was risked and what was won.

That wager—pulling every bird into captivity—was controversial then and remains instructive now. It shows that when extinction in the wild is imminent, triage becomes literal: decisions must be made quickly, and they lock in decades of financial and social commitments.

Who gets the money? Charisma and bias in the ledger

A 2025 analysis of more than 14,000 species‑focused projects from 1992–2016 found that five mammal groups—primates, carnivores, whales, elephants and rhinos—received 86% of available funding, even though they accounted for only about a third of threatened mammal projects. Plants and invertebrates, crucial to pollination and nutrient cycling, received just 6.6%.

A separate study in Proceedings of the National Academy of Sciences reported that global conservation funding is limited and biased, leaving most threatened species unsupported. Together, the picture is plain: funding concentrates where public attention is deepest, not necessarily where extinction risk or ecosystem leverage is greatest.

The bill for biodiversity dwarfs today’s targets

The Kunming‑Montreal Global Biodiversity Framework aims to raise $200 billion a year from public and private sources by 2030. Against that ambition stands a sobering assessment from economists and conservation groups at the Paulson Institute: the world needs an additional $1.3 trillion annually to stop and reverse biodiversity loss.

Set beside an estimated 1 million species now threatened with extinction, the arithmetic is bracing. Even if countries hit the $200 billion target, the remaining gap is many times larger—pressure that will force sharper choices about high‑cost single‑species rescues like the condor versus interventions that benefit many species at once.

Who decides—and who pays—when recovery changes lives?

Conservation reshapes real places. At the 2026 biodiversity conference in Yerevan (Oct. 19–30), delegates are expected to settle how a permanent advisory body created in 2024 will operate and how 30% global conservation targets apply in Indigenous territories. The stakes are practical: participation versus decision‑making power, and how money flows to people on the land.

The risks of getting this wrong are visible elsewhere. In Tanzania’s Ngorongoro Conservation Area, two presidential commissions in March 2026 recommended continuing evictions in the name of wildlife protection, a process that Indigenous advocates say included few Maasai. Species recovery without local consent can fray trust—and fail on the ground.

What these numbers don’t tell us

The figures here don’t specify the dollar cost of the California condor program, nor how much of global species funding reaches birds like condors. They also don’t break down which specific projects will count toward the $200 billion‑per‑year target or how much will go directly to Indigenous‑led conservation. Those omissions matter for judging cost‑effectiveness and equity, but they remain unsettled in the public record cited here.

Why the condor still earns its airtime

With wild numbers reduced to zero in 1987 and hundreds now flying again, the condor proves that species on the brink can be pulled back. It also shows the price of ambition: recovery programs commit societies to long time horizons that compete with thousands of other threatened species for money and attention.

As COP17 hammers out who decides and how the money moves, the lesson from the condor is less about wingspan than governance. Success depended on sustained institutions and social license. If the coming decade can match that persistence—while correcting the documented funding bias—more of those 1 million imperiled species will get a real shot at recovery.

The road from Yerevan

The framework’s $200 billion target is designed to steer national priorities, not dictate species lists. That keeps room for countries to back high‑profile rescues, but it also makes the guardrails in Yerevan—on Indigenous decision‑making and on how 30% targets apply—central to whether spending aligns with both ecological need and local legitimacy.

The condor’s story is a reminder: conservation works best when it adds up on paper and on the ground. The next count that matters isn’t just birds in the air—it’s dollars, decisions, and who gets a seat at the table.

The post Counting condors, counting costs: how a near‑extinct bird spotlights who gets saved — and who decides appeared first on Everyman Science.

A study reported via Nature found that a personalized mRNA vaccine, given after tumour removal, reduced the combined risk of melanoma returning or the recipient dying by 42%. That number, not the headlines, is the point.

Who did this, and where it lands

The finding comes from a phase III trial of a personalized mRNA vaccine known as intismeran, with results reported via Nature and slated for presentation at the European Society for Medical Oncology (ESMO) meeting in Madrid on 24 October. The companies involved released the key results on 22 October after a leak prompted early disclosure.

How the trial actually worked

The intismeran trial enrolled 1,137 people with moderate to advanced melanoma across 157 centres. Participants have so far been followed for around 25 months, with longer monitoring planned to see whether the vaccine improves overall survival, according to trial leader Georgina Long.

To build each person’s vaccine, Long and colleagues sequenced DNA from a sample of the participant’s tumour to identify mutations in the cancer cells. These mutations can give rise to proteins called neoantigens, which help to distinguish cancer cells from healthy ones. The vaccine is tailored to this personal mutation and neoantigen profile.

What the numbers say—no adjectives needed

Headline result: a 42% reduction in the risk of the cancer returning or the recipient dying when the vaccine was used alongside an immunotherapy drug. Oncologists regard a risk reduction of 10% as substantial, says Kristen Radford; Seth Cheetham adds that more than 40% “would send many researchers over the Moon.” The therapy did not result in any major harmful side effects, according to Long, though some people did not respond to the vaccine, as Jessamy Tiffen notes.

Why this matters in melanoma today

Melanoma care has changed dramatically: roughly 15 years ago, people with advanced disease typically survived for only months. Today, nearly 55% are effectively cured with targeted drugs or immunotherapies, says Long. A 42% additional reduction in recurrence or death risk, in people already treated surgically and at risk of relapse, is why many in the field are paying attention.

What isn’t known yet—once, clearly

Participants have only been followed for around 25 months so far, and the trial will continue for several years to measure overall survival. Some people did not respond to the vaccine, and Long’s team will conduct a statistical analysis to identify who is most likely to benefit. As Jessamy Tiffen cautions, only time will tell how effective the treatment is beyond two years.

The market’s whiplash isn’t the science

After data leaked online on 22 October, the companies released the key results. Moderna’s stock price had been rising since August but dropped by around 25% after the leak, according to Evan Seigerman at BMO Capital Markets. He told Forbes the swing likely reflected inflated expectations ahead of the full data release rather than an indictment of the therapy’s efficacy. The biology does not move with the ticker.

Method, revisited: why personalization is the point

To develop intismeran, the team sequenced DNA from each participant’s tumour to identify mutations, then targeted the resulting neoantigens—features that help mark cancer cells as distinct from healthy ones. The logic is straightforward: build the vaccine from what the tumour shows you.

Where this goes next

Long says her team will conduct a statistical analysis to identify who is most likely to benefit. The phase III data are being presented at ESMO on 24 October, and long‑term follow‑up is underway. Those two facts—who benefits most, and how durable the effect remains over years—will decide how widely this approach is used.

The post Built from each tumor, an mRNA vaccine plus immunotherapy cut melanoma’s return‑or‑death risk 42% appeared first on Everyman Science.

The standard story has been simple on paper: dark energy, the thing that makes cosmic expansion speed up, is fixed and unchanging. Fold that assumption into the equations, and the large-scale history of the cosmos adds up neatly. But the largest collection of these exploding stars ever assembled is now providing fresh evidence that dark energy may change over time.

A map built from 2,884 stellar detonations

Type Ia supernovae are the workhorses of cosmic distance measurement. The international research team reports a unified set of 2,884 such explosions drawn from three decades of astronomical observations. Bringing so many events into a single, consistent framework is what lets them trace the universe’s expansion with new precision, and it is what makes this compilation different: scale and uniformity, not just another batch of data.

Team members describe the undertaking as rebuilding three decades of observations into one consistent standard, so that supernova measurements taken years and continents apart could be compared fairly. The result is not just a bigger sample. It is a stricter yardstick applied across the whole timeline those supernovae illuminate.

The assumption under stress: a constant dark energy

Researchers frame the tension plainly. The standard model of cosmology assumes dark energy is fixed and unchanging. If that’s right, a comprehensive supernova record should reinforce the same story we have told for a generation.

Instead, they report more evidence for time variation. The expanded dataset, according to astrophysicist Tamara Davis, marks an important advance in efforts to understand dark energy’s nature, in part because it strengthens the case that the constant-in-time picture may be too simple.

Not one hint but two, from independent paths

This is not a single-team mirage. Researchers point to two completely independent measurements that have found hints of time variation in dark energy. One grew out of Dark Energy Survey findings published in 2024.

A separate astronomical project has also produced evidence suggesting dark energy might not remain constant. Independence matters in cosmology: when different kinds of observations begin to tug in the same direction, it becomes harder to explain the effect away as an artifact of one method.

What changes if dark energy changes

If dark energy evolves over time, the consequence is more than a footnote. It would mean our baseline model of the cosmos needs reworking at its core. The expansion history we infer from supernovae and other tracers would have to accommodate an energy component that shifts as the universe ages, not just a fixed term carried along for the ride.

Researchers also connect the question to deeper theoretical stakes. Understanding dark energy’s behavior could feed into attempts to reconcile gravity with quantum physics—two frameworks that both work extraordinarily well in their domains but do not yet fit together in a single theory.

What’s still up in the air, once and clearly

Hints are not a verdict. The teams describe evidence that points toward time variation, not a final determination that settles the issue. That is why they have gone to the trouble of compiling a dataset this large, and why they are not done adding to it.

The next pieces to add

The researchers plan to expand the dataset as fresh observations roll in. One new vein is already opening: the Dark Energy Bedrock All-Sky Supernova program is identifying hundreds of supernovae, especially at distances closer to Earth than the events that powered much of the recent work.

Folding in those nearby explosions should sharpen the expansion map and test whether the signs of time-varying dark energy hold up. The team’s stance is pragmatic: build the best, cleanest catalog possible and see where the universe points when the statistics are finally big enough to be persuasive.

Why a bigger catalog changes the conversation

Scale is not just bragging rights here. An expanded sample improves the leverage on when and how the expansion rate changes over time. That is the crux of the dark-energy question: fixed, or evolving.

With nearly 3,000 events coherently assembled, and with another independent line of evidence pointing the same way, the conversation is no longer about one intriguing anomaly. It is about whether cosmology’s most convenient assumption—unchanging dark energy—survives contact with a universe that may be more restless than we thought.

The post 2,884 supernovae hint dark energy isn’t constant appeared first on Everyman Science.

The study, published in Water Resources Research (https://doi.org/10.1029/2025wr041695), tallies two decades of change and then zeroes in on the drought years. It is not a story about one bad season; researchers said groundwater depletion has been a persistent problem in the basin over the past two decades, and losses accelerated in 2019. Esther Oyedele, the study’s first author, put the recent spike down to the three-year drought that began in 2020.

By the numbers: who lost how much

Between 2004 and 2023, the Colorado River Basin lost 14 cubic miles (58.3 cubic kilometers) of groundwater, according to the researchers. In the 2020–2022 window, the split between the basin’s two halves was stark: the Upper Basin lost around 4.2 cubic miles (17.5 cubic kilometers), while the Lower Basin lost about 2.3 cubic miles (9.4 cubic kilometers). That “almost twice as much” contrast is the surprise, and it rearranges assumptions about which side is most exposed when the surface system runs short.

The asymmetry matters for people as well as aquifers. Oyedele noted that roughly 30 million of the 40 million people who depend on the river live in the Lower Basin. Those demands, layered on lower natural recharge and higher evaporation in the south, have long made the Lower Basin the expected hotspot. Seeing the Upper Basin shed more groundwater during the drought suggests vulnerability is now shared differently than managers and modelers had assumed.

A river that carries 35% less than it used to

The river’s surface story sets the backdrop. Researchers reported that the Colorado’s flow is now 35% less than it was on average in the 20th century. This is the combined product of warming and the river’s longstanding overallocation. In that context, the study reported that Lake Mead and Lake Powell—keystones of the system—dropped to record lows in August, a visible sign of a water budget that no longer balances.

Groundwater had been the quiet buffer. Researchers said depletion has persisted for two decades, but the drought that began in 2020 was the principal cause of the recent acceleration, according to Oyedele. When the surface cupboard is bare, the pump switch flips more often; the numbers above show how quickly the backstop can erode.

Why the wetter half blinked first

Oyedele said the Lower Basin naturally has less groundwater recharge than the Upper Basin, so the new pattern is not a simple north–south mirror. The Upper Basin’s higher historical recharge also sets up a larger fall when drought bites. That combination helps explain how the Upper Basin could post the bigger loss during 2020–2022 even though the Lower Basin hosts far more people and heat.

The result challenges a comfortable storyline. Oyedele said the Upper Basin is more vulnerable to drought than experts had thought. If that holds in future dry spells, it would force a rethink of how managers divvy up drought risk between river releases and wells in each half of the basin.

What we still don’t know

It’s unclear why the deficit was so much higher in the Upper Basin than in the Lower Basin during the 2020–2022 period. The study’s topline is solid—the measured losses and their contrast—but the mechanism behind the split is not settled. Future groundwater responses will depend on precipitation, snowmelt, water use and management decisions, Oyedele said, and those ingredients do not line up the same way every drought.

Managing one connected system, not two silos

Oyedele argued for managing groundwater and surface water together. That is not a semantic tweak; the study’s numbers show how both sides of the ledger move during shortages, and how relying on groundwater as a limitless backup is a bet the basin has already been losing.

With water scarcity described as alarming and the reservoirs at record lows in August, the math will keep tightening. Continued warming, changes in snowpack, prolonged drought and increasing water demand could add more pressure across both basins, Oyedele said. Whether the next drought repeats the same Upper–Lower contrast, the budget constraint remains the same.

The post The wetter half blinked first—Upper Colorado shed 4.2 cubic miles of groundwater in 2020–22, nearly twice the Lower Basin appeared first on Everyman Science.

That trap is what a team at the Korea Institute of Energy Research (KIER) says it has designed around. Reporting work published in Applied Catalysis B: Environment and Energy, the group led by Dr. Sun‑Mi Hwang describes an exhaust-treatment approach for ammonia-fueled ships that targets multiple pollutants at once. They report roughly 99% removal of the targeted pollutants, at temperatures engines actually see, and at far lower cost than the noble-metal standards the industry knows.

Why this is in the news now

Ammonia is on shipping’s shortlist for cutting carbon, but exhaust cleanup is not a solved problem. In material reported via phys.org, the KIER team frames that cleanup as the most formidable barrier to ammonia-fueled shipping, and presents two catalysts as an all-in-one answer. One runs at 350 °C—approximately 100 °C lower than conventional commercial catalysts and below the high operating temperatures exceeding 450 °C that have been the norm—and the overall system is described as simultaneously and cost‑effectively removing various greenhouse gases from ammonia combustion.

What’s actually new in the hardware

Two claims stand out. First, performance: the team reports approximately 99% removal of the targeted pollutants. Second, practicality: the catalysts are at least 80% less costly than existing noble‑metal alternatives, and total catalyst usage can be reduced by up to 50% because a single layer tackles multiple species at once. Those three numbers—~99%, ≥80%, and up to 50%—are what make this more than a lab curiosity.

The temperature window matters just as much. One of the catalysts is specified to operate at 350 °C. The team contrasts this with conventional commercial catalysts that need temperatures approximately 100 °C higher, and with other options that require high operating temperatures exceeding 450 °C. Running cooler opens doors: it lines up with the heat actually available in exhaust and avoids extra burners or energy penalties.

From kitchen chemistry to ship stacks: how a catalyst helps

If you’ve ever used a self‑cleaning oven, you know heat alone can break down grime. Exhaust cleanup is the same idea with molecules: you steer them onto a surface that makes the hard reactions easy. The analogy breaks down because, unlike an oven’s indiscriminate burn‑off, ship exhaust needs selectivity—turning targeted compounds into harmless nitrogen without making new problems—and it has to do it continuously at the pace of an engine.

According to the KIER team, the new setup aims to handle multiple greenhouse gases from ammonia combustion in one go. That consolidation is why they can claim less total catalyst material and a single layer doing double duty: one pass, fewer parts.

Why not just stick with today’s catalysts?

Cost and heat. Noble‑metal catalysts work but are expensive; the team states their approach is at least 80% less costly than those alternatives. And many incumbent systems want temperatures exceeding 450 °C to do their best work. The KIER catalysts shift that window down to 350 °C for the nitrous‑oxide step and report approximately 100 °C advantage over conventional commercial offerings. Those are not marginal tweaks; they change where you can bolt the unit in and how much you pay for it.

What happens if it falls short aboard a ship

The risk is in what gets through. N2O’s warming punch—roughly 300× CO₂’s global warming potential—means even small leaks matter. The reported ~99% removal target is meant to keep that punch bottled up; missing it would push warming back the wrong way just as shipping is trying to decarbonize.

What we don’t know yet

Key details are not public here: lifetime on real engines, tolerance to contaminants, maintenance intervals, and performance over duty cycles. The reports do not specify those numbers, nor do they list the exact cost breakdown behind the “at least 80% less costly” figure or how the “up to 50%” catalyst reduction scales with engine size. Those are the measurements that will decide whether the lab promise holds at sea.

The potential upside, in one sentence

If an exhaust unit can cost at least 80% less than noble‑metal systems, use up to 50% less catalyst, run at 350 °C rather than the >450 °C many systems demand, and still remove roughly 99% of the targeted pollutants, it directly addresses what Dr. Sun‑Mi Hwang has called the most formidable barrier to ammonia‑fueled shipping.

Where the findings live for the record

The study’s findings are published in Applied Catalysis B: Environment and Energy. For readers who want the technical backbone, see “K‑Ni0.4Co2.6O4 spinel catalysts for low‑temperature catalytic decomposition of N2O: Effects of K on activity and NO/NH3 resistance” (https://doi.org/10.1016/j.apcatb.2026.127204).

The post How a cooler, cheaper catalyst could clean up ammonia-fueled ships appeared first on Everyman Science.

A team at The University of Queensland says yes. In a Nature Protocols paper, they lay out a method called NASTIC that promises single‑molecule, real‑time views of protein behavior in living cells—exactly the kind of mechanistic evidence early drug discovery usually lacks.

Who did this and where it landed

The platform, developed over more than two decades at UQ’s Queensland Brain Institute, is led by professor Frederic Meunier’s team. The protocol itself—titled “Nanoscale spatiotemporal cluster analysis of expressed and endogenous proteins”—is published by Rachel S. Gormal and colleagues in Nature Protocols (2025). The work has been spun out into a Brisbane startup, Accretion Bio, with Phillip Craig as founder and CEO and Meunier and QBI colleague Dr. Tristan Wallis as technology co‑founders.

What the method actually does

NASTIC—short for Nanoscale Spatiotemporal Indexing Clustering—lets researchers follow how key proteins move, form clusters and interact inside living neurons. It enables study of biological processes as they unfold, across space and time, at the single‑molecule level. In practice, that means observing protein behavior in living cells rather than inferring it after the fact from fixed samples.

Because it operates in real time, the same setup can be used to see how a potential drug changes its target’s behavior early in discovery, without waiting for downstream readouts. The University of Queensland describes the view NASTIC provides of neurodegenerative disease progression as “unprecedented,” and Meunier underscores that it captures motion, clustering and interactions where they happen: inside living neurons.

What the study adds—formalizing a new class of evidence

Accretion Bio’s CEO Phillip Craig frames the need simply: for years, drug programs have had to make high‑stakes calls without a crucial layer of mechanistic data about what is happening inside a living cell. In neurodegeneration, he argues, that functional information gap is one reason programs fail late and expensively in the clinic. By letting teams watch how a drug candidate changes a target’s behavior in real time, NASTIC supplies what Craig calls a new class of evidence.

The paper’s contribution is to codify that approach in a protocol—a step‑by‑step way for labs to capture and analyze nanoscale, spatiotemporal clustering of expressed and endogenous proteins. Interest is not purely academic: Queensland reports that industry‑funded research using the platform is already underway at QBI and that global pharmaceutical companies have taken notice. Accretion Bio’s initial focus, fittingly, is neurodegeneration.

Why this matters for Alzheimer’s and Parkinson’s

The hallmarks of many neurodegenerative diseases are proteins that mislocalize, aggregate or mis‑signal. If you can see those changes unfold inside living neurons—and see how an experimental molecule modulates them—you can make sharper go/no‑go decisions much earlier. Meunier notes the platform’s ability to track movement, clustering and interactions; Craig emphasizes the shift from indirect proxies to direct observation of targets in their native context.

Dr. Dean Moss of UniQuest, the university’s commercialization arm, calls the capability powerful and with potential to advance drug discovery globally. Antler Australia partner James McClure points to Accretion Bio’s domain expertise and leadership as reasons it can carry the technology to partners who need it.

What we still don’t know from the paper and launch notes

Some details a reader might expect are not specified in the public descriptions: which disease‑related proteins were demonstrated, the quantitative limits (throughput, duration of live imaging, or error characteristics), and how results compare head‑to‑head with existing approaches. The materials do not list numerical performance metrics, case studies with effect sizes, or validation across multiple cell types beyond living neurons.

It’s also important to note that a Nature Protocols paper is about how to do something reproducibly, not a clinical validation of outcomes. The claims about impact on drug discovery are prospective. Those will be tested as programs run and decisions made with NASTIC‑derived evidence are compared with outcomes downstream.

Limits and next steps, stated plainly

Limitations flagged by the narrative around NASTIC are mostly about scope and stage: it is a platform for observing and analyzing, not a therapeutic by itself. Demonstrating that earlier, mechanistic readouts improve attrition will take time and multiple collaborations. The launch materials do not enumerate constraints such as which neuronal subtypes are amenable or how easily the protocol ports between labs.

Next steps are already in motion: QBI reports industry‑funded projects using the platform, and Accretion Bio is focusing first on neurodegenerative programs. If those efforts show that direct, real‑time observation changes the odds of success, it would validate the central bet behind NASTIC: that seeing target behavior in living neurons is the missing layer many programs needed.

From lab bench to partners who need it

Accretion Bio’s founding by Phillip Craig, with Meunier and Dr. Tristan Wallis as technology co‑founders, formalizes the path from protocol to practice. Queensland notes interest from global pharmaceutical companies, and Craig positions the company to work with pharma and biotech partners while advancing its own neurodegeneration discovery work. Support from UniQuest and investors underscores the ambition to move this capability from a single brain institute to the wider drug discovery community.

The post They filmed single molecules clustering inside living neurons appeared first on Everyman Science.

No one has ever returned a sample from a Martian moon. If all the choreography holds, this will be the first time a mission scoops Phobos and ships the grains home.

A year out to Mars, then in close

The plan stretches over years. MMX is expected to take around a year to reach Mars and enter orbit in August 2027. From there, it will spend time studying Phobos from a distance before closing in.

Phobos is not a forgiving neighbor. The moon circles about 6,000 kilometers above the Martian surface, a realm where gravity is so feeble that a clumsy nudge can become an escape.

A tiny rover that weighs 15 grams

Early in 2029, the spacecraft will release a 25‑kilogram rover called Idefix to Phobos’ surface. The rover has two main jobs: scout for a safe touchdown and probe the surface’s composition and texture.

On Phobos, Idefix will “weigh” the equivalent of about 15 grams. That’s the challenge in a nutshell: instruments and wheels built on Earth must work where down is barely a suggestion.

Designing for a landing where gravity barely helps

Even for the mother ship, the hardest parts aren’t the engines but the legs. JAXA’s engineers have said developing the landing legs was particularly difficult because Phobos’ gravity is extremely weak. In ordinary landings, gravity helps you settle. Here, it threatens to bounce you back into space.

MMX carries 11 science instruments to make the most of its time near the moons. But the headline work happens on the ground—twice.

Two touchdowns, one promise: at least 10 grams

In 2030, the main spacecraft is expected to land on Phobos to collect samples. Mission plans call for two collection landings, giving the team a second try at a different spot or a backup if the first proves stingy.

Between the attempts, the spacecraft is tasked with securing at least 10 grams of material. It is a deliberately modest target—grains and flecks, not jars and rocks—but enough for modern labs to work with for years.

Three years with Phobos, then a turn toward Deimos

MMX will end its close observations of Phobos after about three years. With that work banked, the mission will shift its focus to Deimos for a series of flybys, building a paired picture of Mars’ two small moons.

Near the end of 2030, the spacecraft will attempt to head home. If the trajectory holds, the sample-return capsule is scheduled to reach Earth in 2031 for a landing in Australia before transfer to Japan.

What a 6,000‑kilometer orbit means for operations

Phobos’ path just 6,000 kilometers above Mars complicates everything from navigation to safety margins. The moon sits deep in Mars’ pull, where small errors grow and “hovering” is an active, not a passive, verb.

It also means the spacecraft must repeatedly thread a path between a world and its moon while staying close enough for landings and far enough to keep fuel and time on its side.

What we won’t know until the capsule opens

No one can say in advance what information will be locked in those grains from Phobos, or how evenly the two landings will fill the sample quota. The moon’s surface has only been glanced by flybys; the texture and cohesiveness that matter to a sampler are still mostly guesses.

That is why the plan builds in two attempts and years of reconnaissance first. The science upside is tied to a simple event: a capsule on the ground in Australia with at least 10 grams sealed inside.

A round trip with an eye on the long game

If MMX keeps to its timeline, the return attempt comes in November 2030, with the capsule’s Earth landing in 2031. From the landing site in Australia, the container will be transferred to Japan for sample extraction and sharing with partners.

Getting even a spoonful from Phobos is the point. It is a test of landing gently where gravity barely tugs, of collecting twice, and of threading back from Mars’ neighborhood to a target ellipse on Earth. If the capsule lands with those grains inside, a first in planetary exploration becomes a laboratory reality.

The post On Phobos, down is a suggestion. Japan’s MMX aims to bring 10 grams home appeared first on Everyman Science.